Diarrhoea: Clinical Trials

34 trials for Diarrhoea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 12 Not applicable, 10 Phase 3, 9 Phase 2, 4 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 11, Unknown 1
Phase 310Completed 10
Phase 29Completed 7, Active not recruiting 1, Not yet recruiting 1
Phase 14Completed 3, Active not recruiting 1
Phase 42Completed 1, Withdrawn 1

Follow Diarrhoea: new trials by email Literature Review of Diarrhoea trials Research Report on Diarrhoea

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
AltSonflex1-2-3, Menveo, Infanrix hexa - Diarrhoea
Phase 2Not yet recruitingGlaxoSmithKline5282026-01-022026-01-06
CMTS4520 for Chronic Diarrhoea in Adults
CMTS4520 (dietary fiber and probiotics), Placebo - Diarrhoea
Phase 1 / Phase 2Active not recruitingThe Second Hospital of Nanjing Medical University1002025-02-202025-11-18
A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants
altSonflex1-2-3 Dose A, altSonflex1-2-3 Dose B, altSonflex1-2-3 Dose C - Diarrhoea
Phase 2CompletedGlaxoSmithKline2002024-11-132026-01-30
Racecadotril Versus Standard Treatment in Decreasing the Duration of Acute Diarrhoea in Children
Racecadotril - Diarrhoea
Phase 1 / Phase 2CompletedBenazir Bhutto Hospital, Rawalpindi2602024-08-022026-09-22
A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib
Nintedanib - Idiopathic Pulmonary Fibrosis, Diarrhoea
CompletedBoehringer Ingelheim182024-07-162026-05-13
A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
AltSonflex1-2-3 High Dose, AltSonflex1-2-3 Medium Dose, AltSonflex1-2-3 Low Dose - Diarrhoea
Phase 1 / Phase 2CompletedGlaxoSmithKline5512021-10-062026-06-22
Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda
BCG at birth, Control arm: Delayed BCG - Severe Illness, Septicaemia
Phase 3CompletedMakerere University45002016-07-012025-03-04
Reformulated F75 Milk to Treat Severe Acute Malnutrition
Standard F75 Milk, Modified F75 Milk - Malnutrition, Diarrhoea
Phase 2 / Phase 3CompletedUniversity of Oxford8422014-12-012016-04-14
The Effect of Enteral Nutrition Supplemented With Prebiotics on Colonic Microbiota in the Critically Ill Patients
Prebiotics-free enteral formula, Prebiotics containing enteral formula - Diarrhoea
Not applicableUnknownUniversity of Malaya402014-01-012014-05-21
Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea
IQP-MM-101 - Diarrhoea
Not applicableCompletedInQpharm Group1012013-10-012020-03-04
ICCM of Common Childhood Diseases: Mozambique and Uganda
Technology supported supervision, Community supported supervision, Integrated community case management - Malaria, Pneumonia
Not applicableCompletedMalaria Consortium22892013-04-012016-01-08
Improving the Diagnosis of Diarrhoea in Emergency Rooms
Nasopharyngeal Swab - Diarrhoea
Not applicableCompletedAssistance Publique Hopitaux De Marseille3542013-03-202023-04-21
Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan
Maternal Neonatal and Child Health Interventions - Antepartum Hemorrhage, Postpartum Hemorrhage
Not applicableCompletedAga Khan University150002013-01-012020-06-22
A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate
Idoform Plus, Placebo - Diarrhoea
Phase 4WithdrawnPfizer2013-01-012013-09-24
Causes of Rotavirus Vaccine Failure in Zambian Children
Diarrhoea
CompletedCentre for Infectious Disease Research in Zambia4202012-04-012018-08-23
Can Mass Media Campaigns Reduce Child Mortality
Local radio campaign to reduce under-five child mortality - Diarrhoea, Malaria
Not applicableCompletedLondon School of Hygiene and Tropical Medicine1000002012-03-012015-05-20
Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With Infection
Ready to Use Therapeutic Food (RUTF), Micronutrient Powder (MNP) - Malnutrition, Malaria
Not applicableCompletedMedecins Sans Frontieres, Netherlands22132012-02-012013-10-16
Effects of Bolus and Continuous Nasogastric Feeding on Small Bowel Water Content and Blood Flow
NG bolus feeding over 5 min, Continuous NG feeding over 4 h - Enteral Feeding, Nasogastric Feeding
Phase 1 / Phase 2CompletedUniversity of Nottingham122012-01-012013-05-06
An Efficacy Trial of a Gravity Fed Household Water Treatment Device as a Delivery System for Zinc
Zinc enriched water - Diarrhoea
Not applicableCompletedWageningen University2702011-08-012014-02-28
Study of Alternative Vaccination Schedule of Oral Cholera Vaccine
Modified killed oral cholera vaccine at 14 day interval, Modified killed oral cholera vaccine at 28 day interval - Cholera, Diarrhoea
Phase 2CompletedInternational Vaccine Institute3862010-12-012013-09-25

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Diarrhea (34)  ·  Malaria (4)  ·  Pneumonia (4)  ·  Malnutrition (3)  ·  Dysentery, Bacillary (2)  ·  Gastroenteritis (2)  ·  Anemia (1)  ·  Asphyxia Neonatorum (1)  ·  Body Weight (1)  ·  Breast Feeding (1)  ·  Cachexia (1)  ·  Cholera (1)  ·  Convalescence (1)  ·  Disease (1)  ·  Dysentery (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (34)  ·  Signs and Symptoms (34)  ·  Signs and Symptoms, Digestive (34)  ·  Infections (10)  ·  Digestive System Diseases (5)  ·  Gastrointestinal Diseases (5)  ·  Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Mosquito-Borne Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (4)  ·  Respiratory Tract Infections (4)  ·  Vector Borne Diseases (4)  ·  Bacterial Infections (3)

Interventions

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (3)  ·  Duration of Therapy (2)  ·  Hepatitis B Vaccines (2)  ·  Meningococcal Vaccines (2)  ·  Probiotics (2)  ·  Smectite (2)  ·  Tetanus Toxoid (2)  ·  smecta (2)  ·  Boostrix (1)  ·  Dietary Fiber (1)  ·  Lacteol (1)  ·  Lactose (1)  ·  Osmolite (1)  ·  Rifaximin (1)  ·  Rubella Vaccine (1)

Sponsors

GlaxoSmithKline (4)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (3)  ·  London School of Hygiene and Tropical Medicine (3)  ·  Ipsen (2)  ·  Aga Khan University (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Benazir Bhutto Hospital, Rawalpindi (1)  ·  Boehringer Ingelheim (1)  ·  Centre for Infectious Disease Research in Zambia (1)  ·  Dr. Philipp Zanger, MD MSc DTM (1)  ·  InQpharm Group (1)  ·  International Vaccine Institute (1)  ·  Makerere University (1)  ·  Malaria Consortium (1)  ·  Medecins Sans Frontieres, Netherlands (1)

Countries

Kenya (5)  ·  Bangladesh (3)  ·  India (3)  ·  United Kingdom (3)  ·  Germany (2)  ·  Malaysia (2)  ·  Uganda (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Burkina Faso (1)  ·  Cambodia (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Malawi (1)

Top investigators

Nur H Alam, MD (2)  ·  Thomas Clasen, PhD (2)  ·  Abeed H Chowdhury, BSc MRCS (1)  ·  Amit Saha, MBBS (1)  ·  Chakravarthi Rajkumar (1)  ·  Diego Moretti, PhD (1)  ·  Dipika Sur, MD, DPH (1)  ·  Faming Zhang, PhD (1)  ·  Halvor Sommerfelt, MD, PhD (1)  ·  Hazreen Abdul Majid, BSc(RD),PhD (1)  ·  James A Berkley (1)  ·  Kevin G McGuigan, PhD (1)

Results publications

PMID 20237063, PMID 21936492, PMID 23602437, PMID 23618760, PMID 23976883, PMID 24012319, PMID 25084699, PMID 25442689, PMID 25684587, PMID 26315661, PMID 26859559, PMID 27496512, PMID 28511653, PMID 29433668, PMID 30057798, PMID 30807589, PMID 31775877, PMID 33154417, PMID 33565123, PMID 34538239, PMID 35987625, PMID 37307519, PMID 38853614

NIH funding

R01AI099601 (1)